5Suppliers
6Customers
2Debt Items
20Related Chains

Journey Medical Corporation Suppliers

TickerNameConfidenceEvidence
ORANY ORANY 72% t of assets, we currently, and will continue to, secure manufacturing agreements with either a counterparty to a transaction, with one or more of our contract manufacturers or additional contract man…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from DERM graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from DERM graph: Reciprocal relationship from ORAN…
RDY Dr. Reddy's Laboratories Limited 72% Reciprocal relationship from RDY graph: Reciprocal relationship from DERM graph: Reciprocal relationship from RDY graph: Reciprocal relationship from DERM graph: Reciprocal relationship from RDY grap…
VYNE VYNE Therapeutics Inc. 72% er serious labor problems that have materially impeded our business operations. Our human capital management objectives include, as applicable, identifying, recruiting, retaining, incentivizing, and …
VYNE VYNE Therapeutics Inc. 72% Reciprocal relationship from VYNE graph: Reciprocal relationship from DERM graph: Reciprocal relationship from VYNE graph: Reciprocal relationship from DERM graph: er serious labor problems that have…

Journey Medical Corporation Customers

TickerNameConfidenceEvidence
CUTIA CUTIA 92% Other revenue for the three-month period ended March 31, 2026 reflects sales-based royalties earned on the net sales of Amzeeq by Cutia.
ORANY ORANY 72% t of assets, we currently, and will continue to, secure manufacturing agreements with either a counterparty to a transaction, with one or more of our contract manufacturers or additional contract man…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from DERM graph: t of assets, we currently, and will continue to, secure manufacturing agreements with either a counterparty to a tra…
RDY Dr. Reddy's Laboratories Limited 72% Reciprocal relationship from RDY graph: ell lung cancer following the results of the futility analysis. As a result, the Company recorded an impairment loss of Rs. 914 (U.S.$ 10 ) in the consolidated…
VYNE VYNE Therapeutics Inc. 72% er serious labor problems that have materially impeded our business operations. Our human capital management objectives include, as applicable, identifying, recruiting, retaining, incentivizing, and …
VYNE VYNE Therapeutics Inc. 72% Reciprocal relationship from VYNE graph: Reciprocal relationship from DERM graph: Reciprocal relationship from VYNE graph: Reciprocal relationship from DERM graph: er serious labor problems that have…

Journey Medical Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
DERM-DEBT-9053 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
DERM-DEBT Debt stack $25.5M 90% Market cache reports total debt of $25.5M.

Journey Medical Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Journey Medical Corporation.

Journey Medical Corporation Ownership

HolderNameConfidenceEvidence
DERM-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 71 tracked holders.

Journey Medical Corporation Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
RDY Dr. Reddy's Laboratories Limited 100.00 1 ['customer', 'supplier']
VYNE VYNE Therapeutics Inc. 100.00 1 ['customer', 'supplier']
ORANY ORANGE 100.00 1 ['customer', 'supplier']
TGTX TG Therapeutics, Inc. 100.00 2
MBIO Mustang Bio, Inc. 100.00 2
OCSL Oaktree Specialty Lending Corporation 100.00 2
CUTIA CUTIA 63.48 1 ['receiving']
D Dominion Energy, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
AMZE Amaze Holdings, Inc. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
IMMP Immutep Limited 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
AMRX Amneal Pharmaceuticals, Inc. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
AZN AstraZeneca PLC 50.00 2